Global Rapid Diagnostic Test Kits Market Set for Strong Expansion, Reaching $32.21 Billion With 5.9% CAGR by 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the rapid diagnostic test kits market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Rapid Diagnostic Test Kits Market in 2030?

The rapid diagnostic test kits market has demonstrated robust expansion recently. Its value is anticipated to rise from $24.08 billion in 2025 to $25.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This past growth is largely a result of the increasing prevalence of infectious diseases, the broadening of decentralized healthcare services, a growing need for rapid diagnostic outcomes, the rise in outpatient and homecare testing, and the accessibility of lateral flow and immunoassay technologies.

The market for rapid diagnostic test kits is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $32.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This projected expansion is driven by factors such as greater investments in rapid diagnostic innovation, the rising popularity of self-testing kits, the enlargement of infectious disease surveillance initiatives, the escalating need for cost-effective diagnostics in developing regions, and the broader incorporation of digital readout technologies. Key trends anticipated during this period encompass the increasing embrace of point-of-care testing solutions, a heightened demand for multiplex rapid test kits, the expanding utilization of diagnostics at home, the proliferation of portable and disposable test formats, and a sharpened emphasis on detecting diseases early.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24678&type=smp

What Drivers Are Influencing Production Trends In The Rapid Diagnostic Test Kits Market?

The expansion of the rapid diagnostic test kits market is anticipated to be driven by the escalating prevalence of infectious diseases. These diseases are defined as illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, which can transmit directly or indirectly between individuals. The rising incidence of infectious diseases is fueled by antimicrobial resistance and evolving pathogen strains; widespread antibiotic use has resulted in drug-resistant bacterial infections, while viruses continuously mutate, forming new variants that bypass existing immunity and demand updated detection methods. This growing prevalence supports an increased adoption of point-of-care testing devices, enabling rapid identification of pathogens and allowing healthcare providers to promptly diagnose infections, initiate suitable treatment, and implement timely infection control measures. For example, according to the Centers for Disease Control and Prevention, a US-based government agency, in March 2024, the count of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking a surge of 1,295 cases. Consequently, the increasing prevalence of infectious diseases is a significant catalyst for the growth of the rapid diagnostic test kits market.

Which Segment Groups Are Influencing The Rapid Diagnostic Test Kits Market?

The rapid diagnostic test kits market covered in this report is segmented –

1) By Product Type: Antigen Test Kits, Antibody Test Kits, Nucleic Acid Test Kits, Multi-Analyte Test Kits

2) By Technology: Fluorescent Immunoassay, Enzyme-Linked Immunosorbent Assay (ELISA), Colloidal Gold-Based Test, Lateral Flow Assays

3) By Application: Infectious Disease Testing, Cardiology Testing, Oncology Testing, Pregnancy And Fertility Testing, Toxicology Testing, Glucose Monitoring, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Home Care Settings, Pharmacies

Subsegments:

1) By Antigen Test Kits: COVID-19 Antigen Test Kits, Influenza Antigen Test Kits, Malaria Antigen Test Kits, Respiratory Syncytial Virus Antigen Test Kits, Streptococcus Antigen Test Kits

2) By Antibody Test Kits: HIV Antibody Test Kits, Hepatitis Antibody Test Kits, COVID-19 Antibody Test Kits, Dengue Antibody Test Kits, Syphilis Antibody Test Kits

3) By Nucleic Acid Test Kits: HIV Nucleic Acid Test Kits, Hepatitis B And C Nucleic Acid Test Kits, Human Papillomavirus Nucleic Acid Test Kits, Tuberculosis Nucleic Acid Test Kits, COVID-19 Nucleic Acid Test Kits

4) By Multi-Analyte Test Kits: Respiratory Panel Test Kits, Sexually Transmitted Infections Panel Test Kits, Gastrointestinal Panel Test Kits, Febrile Illness Panel Test Kits, Sepsis Marker Panel Test Kits

Which Trends Are Guiding The Evolution Of The Rapid Diagnostic Test Kits Market?

Leading entities within the rapid diagnostic test kits sector are concentrating efforts on creating innovative products, including saliva-based pregnancy test kits, to enhance their market competitiveness. These saliva-based kits serve as diagnostic instruments engineered to identify pregnancy through the analysis of a woman’s saliva for specific hormonal shifts, notably human chorionic gonadotropin (hCG), a hormone generated during gestation. As an illustration, during February 2023, Abingdon Health plc, a diagnostics firm situated in the UK focusing on near-patient solutions, introduced Salistick. This product represents the initial rapid saliva-based pregnancy test available in the UK and Ireland, signifying a notable advancement in at-home pregnancy screening by providing a cleaner and more convenient option compared to conventional urine-based methods. This exceptionally precise test identifies the pregnancy hormone ß-hCG within saliva, facilitating early pregnancy detection for women in any location and at any moment, simultaneously fostering a more intimate and easily shareable testing process.

Who Are The Core Companies Influencing Trends In The Rapid Diagnostic Test Kits Market?

Major companies operating in the rapid diagnostic test kits market are F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Hologic Inc, bioMerieux SA, QuidelOrtho Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Cepheid Inc, OraSure Technologies Inc, Nova Biomedical Corporation, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, ACON Laboratories Inc, Fluxergy LLC, Lumos Diagnostics Holdings Limited, Abingdon Health plc, Abionic SA

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/rapid-diagnostic-test-kits-global-market-report

Which Regions Are Projected To Dominate The Rapid Diagnostic Test Kits Market In The Coming Years?

North America was the largest region in the rapid diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Rapid Diagnostic Test Kits Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24678&type=smp

Browse Through More Reports Similar to the Global Rapid Diagnostic Test Kits Market 2026, By The Business Research Company

Rapid Strength Concrete Market Report 2026

https://www.thebusinessresearchcompany.com/report/rapid-strength-concrete-global-market-report

Lateral Flow Immunoassay Based Rapid Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Covid 19 Rapid Test Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795